FocalTherics said it priced an underwritten public offering of 8,425,000 American Depositary Shares, or ADSs (U.S.-traded shares representing foreign stock), at $4.75 each, raising expected gross proceeds of about $40.0 million before discounts, commissions and other expenses. The ADSs, each representing one ordinary share with a nominal value of €0.13, are all being sold by the company. The offering is expected to close on Aug. 14, 2026, subject to customary conditions. TD Cowen and Mizuho are serving as joint book-running managers, while H.C. Wainwright & Co. and Lucid Capital Markets are acting as co-managers. FocalTherics said the underwriters also have a 30-day option to buy up to 1,263,750 additional ADSs at the public offering price, less underwriting discounts and commissions. The company is conducting the sale under an SEC (U.S. securities regulator) shelf registration statement on Form S-3 that was filed on March 25, 2026, amended on March 27, 2026, and declared effective on March 31, 2026. It added that the securities are being offered only through a written prospectus and prospectus supplement, and said no public offering of the ADSs will be made in Europe.